30 Day Trial

ORTHOKNOW content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Quarterly Review

3Q13 Revenue: Symmetry Surgical

$98MM, -3%

  • Instruments $27.2MM, -8%
  • Implants $26.1MM, +2%
  • Cases $17MM, +20%
  • Other (includes Aerospace) $5.5MM, -18%
  • Surgical $22.2MM, -10%


  • Aside from customer investment in larger product launches, not seeing significant capital spend on instruments and cases
  • Participating in recent new knee platform launch, but with lower level than originally targeted for instruments
  • Supplier rationalization for instrument sourcing not yielding significant volume, but is creating incremental price pressure
  • Some positive signs of improvement in orthopaedic procedure volumes, but too early to call it a trend